Variable-Pulse Nd:YAG Laser in the Treatment of Facial Telangiectasias

Bevin, Avery A.; Parlette, Eric C; Domankevitz, Yacov; Ross, E. Victor

doi:10.1111/1524-4725.2006.32001

Cited by 20 publications

(40 citation statements)

References 19 publications

(30 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Unfortunately, there was no formal quantification of pain levels nor was there any comparison to pain levels when the cryogen spray was not used. A study by Bevin et al 7 used a significantly higher fluence (226–425 J/cm 2 ), using even higher fluencies for smaller vessels. Interestingly, patients were reported to experience only minor pain; however, this was not quantified.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment

Bonaparte

Ellis

2014

Plastic and Reconstructive Surgery Global Open

View full text Add to dashboard Cite

Background:Treatments for cosmetically unpleasing periocular and lateral temporal veins are limited. The purpose of this study was to test the hypothesis that the application of topical lidocaine before the cosmetic treatment of periorbital and lateral temporal veins with a neodymium-doped yttrium aluminum garnet (ND:YAG) laser will result in a significant reduction in subjective pain compared with placebo as assessed using a visual analogue scale.Methods:Twenty patients who required bilateral treatment of facial veins were randomly assigned to receive either placebo or 30% lidocaine gel applied topically over the veins, a split-body design. Both the investigator and the patient were blinded to the treatment. An ND:YAG laser was used to treat the veins. Patients completed a visual analogue scale to assess the pain on each side of the face. Data were analyzed using nonparametric data testing.Results:There was a 64.0% reduction in pain on the treatment side compared with the placebo side (P < 0.001). There was no significant difference in patient-assessed subjective efficacy between sides (P = 0.2). Complications were minimal and mild.Conclusions:Patients undergoing periorbital and temporal vein ablation using ND:YAG laser should be offered topical lidocaine as the pain levels are moderate. The use of topical 30% lidocaine results in a significant reduction in pain levels.

show abstract

Section: Discussionmentioning

confidence: 99%

“…5,6 Even though noninvasive, patients commonly report significant pain and discomfort when undergoing the treatment. 4,7 …”

mentioning

confidence: 99%

Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment

Bonaparte

Ellis

2014

Plastic and Reconstructive Surgery Global Open

View full text Add to dashboard Cite

show abstract

“…Yüzdeki telanjiyektazilerin çoğu kolaylıkla kollabe olan venül kaynaklı dilate damarlar olabilmektedir. Ancak, ala nasi ve burun ucu bölgesindeki telanjiyektaziler nazal arterin lateral dallarıdır ve venüllere kıyasla aynı enerji dozunda daha zor kollabe olduğu için tedaviye daha zor yanıt vermektedir [18][19][20] . Rozase tedavisinde IPL(500-1200nm) etkinliğine dair çalışmalarda hastalarda ortalama 4 seans sonunda %70-80 oranında düzelmeler kaydedilmiştir.…”

Section: Discussionunclassified

Treatment of rosacea with long-pulsed Nd: YAG laser

Say¹,

Gökdemir²

2013

TURKDERM

View full text Add to dashboard Cite

ÖzetAmaç: Rozase genellikle yüz bölgesine sınırlı kronik inflamatuvar bir dermatozdur. Küratif bir tedavisi olmadığı için relapslarla seyreder. Hastalıkta görülen vasküler lezyonlar ve flushing atakları hasta için oldukça rahatsız edici bir durumdur. Kullanılan topikal ve oral antibiyotikler bu lezyonlar için etkili değildir. Son yıllarda rozasenin vasküler lezyonları için çeşitli lazer sistemleri kullanılmıştır. Rozasenin eritem ve telanjiyektatik lezyonlarında uzun atımlı Nd: YAG lazerin etkinliğini araştırmaktı. Gereç ve Yöntemler: Çalışmaya rozasenin eritematotelanjiektatik (ETR) evresinde bulunan 39 hasta (29 kadın, 10 erkek) alındı. Hastaların demografik ve hastalığına ait veriler bir forma kaydedildi. Her hasta için 0-3 arasında değişen "hastalık şiddet" skoru hesaplandı. Uzun atımlı Nd: YAG lazer ile lezyonların olduğu bölgelere 3-4 hafta ara ile uygulama yapıldı. Tedavi öncesi ve sonrasında fotoğrafları çekildi. Hastaların lezyonları 7 ayrı anatomik bölgeye ayrılarak incelendi. Tedavi başarısı araştırmacı tarafından fotoğraflara bakılarak değerlendirildi. Hasta memnuniyeti için hastalara 0-3 skalası kullanıldı. Bulgular: Hastalara ortalama 3,95 seans (2-8 seans) uygulama yapıldı. Şiddet skorlarına göre hastalar; 12 hasta ETR-1, 9 hasta ETR-2 ve 18 hasta ETR-3 olarak gruplandı. Tedavi sonrasında hesaplanan şiddet skorlarındaki değişimlerin istatistiksel olarak anlamlı olduğu görüldü (p<0,05). Tedaviden en iyi yanıt alan grubun ETR-1 (%91,70) olan hasta grubu olduğu ve hastalık şiddeti arttıkça alınan yanıtın azaldığı saptandı. Lezyonların en sık gözlendiği 3 bölge sırasıyla malar bölge, ala nasi ve nazal dorsum bölgesiydi. En başarılı bölge çene bölgesi iken, en başarısız bölge ala nasi olarak gözlendi. Araştırmacı tarafından hastaların yaklaşık %97'sinde tedavi orta derecede başarılı veya başarılı olarak bulundu. Hastaların %61,5'i tedavi sonucunu mükemmel olarak değerlendirdi. Sadece 1 hastada hipopigmente atrofik skar görüldü. Sonuç: Uzun atımlı Nd: YAG lazer, rozasenin vasküler lezyonlarında güvenli ve etkili bir tedavi seçeneğidir. (Türkderm 2013; 47: 45-9) Anah tar Ke li me ler: Rozase, eritem, telanjiyektazi, Nd: YAG lazer, lazer Sum maryBackground and Design: Rosacea is a chronic inflammatory disorder of the face. There is no curative treatment for the disease. Facial flushing and vascular lesions due to rosacea may significantly affect a patient's quality of life. Topical and oral antibiotics are not effective for treating rosacea. Currently, laser treatment of vascular lesions has been reported in the literature. We aimed to investigate the efficacy of long-pulse 1064-nm neodymium: YAG (Nd: YAG) laser in the treatment of vascular lesions (erythema and telangiectasia) in rosacea patients. Materials and Methods: Thirty-nine patients (29 women, 10 men) with erythematotelangiectatic rosacea (ETR) were recruited into the study. Severity of the disease (ETR-score: 0-3) was assessed for all patients. We used long-pulsed Nd: YAG laser for vascular lesions at 3-4 weeks intervals. The face was divided ...

show abstract

“…Srinivas and Kumaresan suggested that the best treatment option for telangiectasias of the lower extremities is achieved with 1064 nm Nd:YAG laser, as its leads to in-depth penetration (5-6 mm), reaching deeply located vessels such as these characterising this particular condition [60] . The use of this laser device was also proposed by other researchers for the treatment of deeper vascular lesions, who also underlined that to avoid overheating of the skin and textural changes, the use of a cooling devise is necessary [61] . The Nd:YAG laser is also a treatment of choice for telangiectasia of darker skin (Fitzpatrick IV-V), as the long wavelength enables deep penetration but minimum absorbance by melanin [62] .…”

Section: Telangiectasiasmentioning

confidence: 99%

Management of vascular lesions using advanced laser technology

Tzermias¹,

Eleftheriadi²,

Gkiouzepaki³

2017

J Surg Dermatol

View full text Add to dashboard Cite

Abstract:One of the most widely used cutaneous applications of Light Amplification by Stimulated Emission of Radiation (laser) concerns the treatment of vascular lesions. During the past two decades, very significant advances in the application of laser technology in dermatology have occurred, with selective photothermolysis being the most important. This review focuses on the application of modern laser devices (Pulsed Dye Laser, or PDL; potassium titanyl phosphate laser, or KTP; diode laser; and neodymium-doped yttrium-aluminium-garnet laser, or Nd:YAG), as well as the combination of laser and photodynamic therapy (PDT) for the treatment of vascular lesions. In lar, both congenital (haemangiomas and port-wine stains) and acquired vascular lesions (facial and leg telangiectasias, rosacea, Poikiloderma of Civatte, spider angioma, pyogenic granuloma, and venous lakes) are discussed. The review of many recent research studies demonstrates that modern applications of lasers in dermatology constitute the finest method for the treatment of vascular lesions, combining the advantages of invasive therapy with the security offered by non-invasive therapy, while in certain cases they are the single and only choice for the treatment of these lesions.Keywords: Va scular lesions; laser; PDL; Nd:YAG; PDT Citation: Tzermias C, Eleftheriadi A, Gkiouzepaki I. Management of vascular lesions using advanced laser technology.

show abstract

Variable-Pulse Nd:YAG Laser in the Treatment of Facial Telangiectasias

Abstract: A small-spot size Nd:YAG laser using a pulse width of 20 ms or higher appears to be effective in clearing a significant percentage of facial telangectasias with a single pass. The side effects were minimal.

Cited by 20 publications

References 19 publications

Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment

Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment

Treatment of rosacea with long-pulsed Nd: YAG laser

Management of vascular lesions using advanced laser technology

Contact Info

Product

Resources

About